Adult Accuracy Study of the Enlite 3 Glucose Sensor

NACompletedINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Type 1 DiabetesType 2 Diabetes
Interventions
DEVICE

Enlite 3

Use of Enlite 3 Sensor over 168 hours (7 days) when inserted in the abdomen \& arm used with the Guardian Mobile App and 640G Pump in subjects aged 14-75 years who have had a diagnosis of type 1 or type 2 diabetes for at least one year.

DEVICE

Guardian Mobile App

DEVICE

640G Insulin Pump

Trial Locations (6)

30318

Atlanta Diabetes Associates, Atlanta

80045

Barbara Davis Center for Childhood Diabetes, Aurora

Barbara Davis Center, Aurora

92026

AMCR Institute, Escondido

94598

Diablo Clinical Research, Walnut Creek

98057

Rainier Clinical Research Center, Renton

All Listed Sponsors
lead

Medtronic Diabetes

INDUSTRY

NCT02246582 - Adult Accuracy Study of the Enlite 3 Glucose Sensor | Biotech Hunter | Biotech Hunter